TY - JOUR
T1 - Epigenetic landscape links upper airway microbiota in infancy with allergic rhinitis at 6 years of age
AU - Morin, Andréanne
AU - McKennan, Chris G.
AU - Pedersen, Casper Emil T.
AU - Stokholm, Jakob
AU - Chawes, Bo L.
AU - Malby Schoos, Ann Marie
AU - Naughton, Katherine A.
AU - Thorsen, Jonathan
AU - Mortensen, Martin S.
AU - Vercelli, Donata
AU - Trivedi, Urvish
AU - Sørensen, Søren J.
AU - Bisgaard, Hans
AU - Nicolae, Dan L.
AU - Bønnelykke, Klaus
AU - Ober, Carole
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020/12
Y1 - 2020/12
N2 - Background: The upper airways present a barrier to inhaled allergens and microbes, which alter immune responses and subsequent risk for diseases, such as allergic rhinitis (AR). Objective: We tested the hypothesis that early-life microbial exposures leave a lasting signature in DNA methylation that ultimately influences the development of AR in children. Methods: We studied upper airway microbiota at 1 week, 1 month, and 3 months of life, and measured DNA methylation and gene expression profiles in upper airway mucosal cells and assessed AR at age 6 years in children in the Copenhagen Prospective Studies on Asthma in Childhood birth cohort. Results: We identified 956 AR-associated differentially methylated CpGs in upper airway mucosal cells at age 6 years, 792 of which formed 3 modules of correlated differentially methylated CpGs. The eigenvector of 1 module was correlated with the expression of genes enriched for lysosome and bacterial invasion of epithelial cell pathways. Early-life microbial diversity was lower at 1 week (richness P =.0079) in children with AR at age 6 years, and reduced diversity at 1 week was also correlated with the same module's eigenvector (ρ = −0.25; P = 3.3 × 10−5). We show that the effect of microbiota richness at 1 week on risk for AR at age 6 years was mediated in part by the epigenetic signature of this module. Conclusions: Our results suggest that upper airway microbial composition in infancy contributes to the development of AR during childhood, and this trajectory is mediated, at least in part, through altered DNA methylation patterns in upper airway mucosal cells.
AB - Background: The upper airways present a barrier to inhaled allergens and microbes, which alter immune responses and subsequent risk for diseases, such as allergic rhinitis (AR). Objective: We tested the hypothesis that early-life microbial exposures leave a lasting signature in DNA methylation that ultimately influences the development of AR in children. Methods: We studied upper airway microbiota at 1 week, 1 month, and 3 months of life, and measured DNA methylation and gene expression profiles in upper airway mucosal cells and assessed AR at age 6 years in children in the Copenhagen Prospective Studies on Asthma in Childhood birth cohort. Results: We identified 956 AR-associated differentially methylated CpGs in upper airway mucosal cells at age 6 years, 792 of which formed 3 modules of correlated differentially methylated CpGs. The eigenvector of 1 module was correlated with the expression of genes enriched for lysosome and bacterial invasion of epithelial cell pathways. Early-life microbial diversity was lower at 1 week (richness P =.0079) in children with AR at age 6 years, and reduced diversity at 1 week was also correlated with the same module's eigenvector (ρ = −0.25; P = 3.3 × 10−5). We show that the effect of microbiota richness at 1 week on risk for AR at age 6 years was mediated in part by the epigenetic signature of this module. Conclusions: Our results suggest that upper airway microbial composition in infancy contributes to the development of AR during childhood, and this trajectory is mediated, at least in part, through altered DNA methylation patterns in upper airway mucosal cells.
KW - Allergic rhinitis
KW - DNA methylation
KW - early life
KW - gene expression
KW - microbiota
KW - upper airways
UR - http://www.scopus.com/inward/record.url?scp=85089579128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089579128&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2020.07.005
DO - 10.1016/j.jaci.2020.07.005
M3 - Article
C2 - 32693091
AN - SCOPUS:85089579128
SN - 0091-6749
VL - 146
SP - 1358
EP - 1366
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 6
ER -